Global Organoids Market Overview
The key driver impacting the Organoids market is the growing incidence and high prevalence of chronic and infectious diseases. For instance, following the World Health Organization (WHO)report, Infectious diseases are the foremost cause of death globally, mainly in low-income nations, particularly in young children. In 2019, two infectious diseases - diarrheal diseases and lower respiratory infections were ranks in the top ten death causes worldwide. The organoids applications emerge as an essential tool in the field of cell biology, gene therapy, regenerative medicine, cancer research, and disease modeling, drug discovery & personalized medicine, which is surging the market growth. Moreover, the increasing demand for biobanking and tumor modeling contributes to Organoid's market demand in the later years.
According to Value Market Research, the global Organoids market size was valued at about USD 5.14 BN in 2022 and is estimated to grow at a CAGR of around 21.34% during the forecast period 2023 to 2030.
The rise in the adoption of organoids to mimic intratumor diversification in culture will likely augment organoids demand in the forecast period. It is because organoids can be easily derived and expanded from single cancer cells. Also, increasing collaborations between researchers and medical experts are anticipated to accelerate the development of complex organoids is encouraging market growth. However, the high cost of manufacturing and installation associated with organoids hinder the market in the coming years. In addition, concerns regarding data security create a considerable challenge to the market growth. Nevertheless, the market trends, such as the advancements in organoid technology and growing research and development, might offer considerable opportunities to the market's leading players.
The Organoids market is wide, with several international and local and players. The market leaders follow many strategies such as amalgamation, extending product portfolio, acquisitions, contracts, product upgrades to strengthen their market share globally. The key players in the report are STEMCELL Technologies, Inc., Hubrecht Organoid Technology, 3Dnamics, Inc, Definigen, PeproTech, Inc., Corning Incorporated (Life Sciences), Cellesce Ltd., Organoid Therapeutics, Thermo Fisher Scientific, and Merck KGgA.
Global Organoids Market Share by Region (Representative Graph)
Analysis by Type:
By type, the report is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment dominates with the highest market share in 2020. It is due to the rise in prevalence of inflammatory bowel diseases (IBD) across the globe. Moreover, the changing lifestyle leads to the occurrence of lifestyle-related diseases that contributes to the growth of the intestine segment in the forecast period.
Analysis by Application:
By application, the report is divided into regenerative medicine, developmental biology, disease pathology of infectious disease, drug discovery & personalized medicine, drug toxicity and efficacy testing, and others. The developmental biology segment dominates with a significant market share in 2020. It is because it is considered a primary investigative research tool of human developmental biology. Moreover, organoids derived from embryonic stem cells offer a complete understanding of the embryonic process development and insights on the development of the stem cells, which is enhancing the developmental biology segment growth.
Analysis by Source:
By source, the report is segmented into Pluripotent Stem Cells (hIPSCs) and Organ-specific Adult Stem Cells (ASCs). The pluripotent stem cells (hIPSCs) segment dominates the source segment with the highest share in 2020. It is due to the huge preference for pluripotent stem cells owing to their ability to divide indefinitely for conducting basic research. Moreover, it has extensive therapeutic applications that contribute to the growth of the pluripotent stem cells (hIPSCs) segment.
Analysis by Region:
In the regional overview of the global Organoids market, the North America region dominates with the largest market share in 2020. It is due to the commercialization of organoid models and the increase in the implementation of organoid-based examination models in the biotechnology industry in the United States and Canada. The increased per capita healthcare spending and favorable healthcare policies support the introduction of organoids. Moreover, the rise in patients suffering from various diseases, increase in investment in stem cell research add to the high market growth across the North America region.
Market Segmentation covered in the Report:
By Type
- Stomach
- Intestine
- Liver
- Pancreas
- Lung
- Brain
- Kidney
- Others
By Application
- Developmental Biology
- Disease Pathology of Infectious Disease
- Regenerative Medicine
- Drug Toxicity and Efficacy Testing
- Drug Discovery & Personalized Medicine
- Others
By Source
- Pluripotent Stem Cells (hIPSCs)
- Organ-speci?c Adult Stem Cells (ASCs)
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.